Research and Markets: Global Continuous Glucose Monitoring System 2014 - 2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/85wvzp/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System 2014 - 2020" report to their offering.

Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from Finger based self-monitoring blood glucose devices. SMBG devices are cheaper and easy to use and are easily approved by the authorities. SMBG has more number of players and larger market share.

However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. . CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for pediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers.

Global Continuous Glucose Monitoring System Market

  • CGM Market
  • Real Time Monitoring
  • Integrated Insulin Pumps
  • Blood Glucose
  • Manufacturers
  • Global Health
  • IPRO Glucose
  • MARD
  • SMBG
  • Growing Diabetic Population
  • Type 1 & 2 Diabetes
  • Nocturnal Hypoglycemia

Key Topics Covered:

Chapter 1. Executive Summary

Chapter 2. Market Overview

Chapter 3. Market Determinants

Chapter 4. Sector Analysis: Diabetes Care

Chapter 5. Cgms Market By Devices

Chapter 6. By Application

Chapter 7. Competitive Intelligence

Chapter 8. Market Share Analysis

Chapter 9. Geographical Analysis

Chapter 10. Corporate Profile: Benchmark Study

  • Medtronic Inc.
  • Dexcom
  • Abbott
  • Johnson And Johnson (J&J) (Animas Corp)
  • Insulet Corp
  • Tandem Diabetes
  • Echo Therapeutics

For more information visit http://www.researchandmarkets.com/research/85wvzp/global_continuous

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices